ALLYSON SMITH: Open Payments
NPI 1710668553 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 18 payments from 11 companies in 2025. Trend: 2023 $467 · 2024 $1,148 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $172 |
| ABIOMED | 1 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| CVRx, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: ELIQUIS, JARDIANCE, LEQVIO, VYNDAQEL, AMVUTTRA, Barostim Neo System, VERQUVO, LifeVest.
Industry payments across AZ — which companies pay providers there.
